| Literature DB >> 30652537 |
Don S Dizon1, Mina S Sedrak1, Mark A Lewis1, Elise Cook1, Michael J Fisch1, Jennifer R Klemp1, Jonathan Sommers1, AnneMarie Ciccarella1, Julie Gralow1, Wendy Lawton1, Craig Nichols1.
Abstract
Progress toward improvement in cancer therapy relies on clinical trials. Yet, only a minority of eligible patients with cancer enroll as a result of multiple barriers at the patient, investigator, center, and national level. However, the rise of the Internet and mobile technology has created a slew of tools with medical applications, from Web sites to apps to social media platforms, all of which may aide clinicians in our quest to improve the clinical research enterprise. SWOG is one of five members in the National Cancer Institute's National Clinical Trials Network-the nation's oldest and largest publicly funded cancer research network-and is taking a leadership role in exploring and testing the promise of digital engagement through the empaneling of the Digital Engagement Committee. This article outlines the mission, principles, and priorities of the Digital Engagement Committee and proposes how this work may inform the use of digital tools for the cancer research community and, hopefully, translate to improved outcomes for our patients.Entities:
Mesh:
Year: 2018 PMID: 30652537 PMCID: PMC6668704 DOI: 10.1200/CCI.17.00122
Source DB: PubMed Journal: JCO Clin Cancer Inform ISSN: 2473-4276